Description
Dianorm-M Tablets
Composition
Dianorm-M tablets contain metformin hydrochloride and glyclazide as active ingredients.
Mechanism of Action
Dianorm-M works by enhancing insulin sensitivity and reducing hepatic glucose production. Metformin improves peripheral glucose uptake while glyclazide stimulates insulin release from pancreatic beta cells.
Pharmacological Properties
The combination of metformin and glyclazide in Dianorm-M offers complementary mechanisms to regulate blood glucose levels effectively. Metformin reduces hepatic glucose output and increases insulin sensitivity, whereas glyclazide stimulates insulin secretion, leading to improved glycemic control.
Indications for Use
Dianorm-M tablets are indicated for the management of type 2 diabetes mellitus to achieve optimal blood sugar control.
Contraindications
Avoid using Dianorm-M if you have a history of hypersensitivity to metformin or sulfonylureas, severe renal impairment, or metabolic acidosis.
Side Effects
Common side effects of Dianorm-M may include gastrointestinal disturbances, hypoglycemia, and skin reactions. Consult your healthcare provider if you experience any adverse effects.
Usage Instructions
Take Dianorm-M as prescribed by your healthcare provider. The typical dosage regimen involves oral administration with meals to minimize gastrointestinal discomfort.
Benefits Over Analogues
Dianorm-M offers superior glycemic control compared to individual metformin or glyclazide therapy. The synergistic action of both components leads to better blood sugar management and reduced risk of diabetic complications.
Suitable Patient Groups
Dianorm-M is suitable for adult patients with type 2 diabetes, including the elderly population. However, individual dosage adjustments may be necessary based on renal function and overall health status.
Storage and Shelf Life
Store Dianorm-M tablets in a cool, dry place away from direct sunlight and moisture. Check the expiration date on the packaging and do not use expired medication.
Packaging Description
Dianorm-M is available in a pack containing 60 tablets. Each tablet is film-coated for easy swallowing and protection of the active ingredients.
Clinical Evidence and Proven Effectiveness
Dianorm-M tablets have demonstrated significant efficacy in managing blood glucose levels in patients with type 2 diabetes. Clinical studies have highlighted the synergistic effects of metformin and glyclazide in improving insulin sensitivity and reducing hyperglycemia.
The combination therapy of metformin and glyclazide in Dianorm-M has been shown to effectively lower HbA1c levels and decrease the incidence of diabetes-related complications, supporting its role as a cornerstone in diabetes management.